Stem Cell Banking Market Size Projected to Reach USD 16.55 Billion, Globally, by 2030 at 15.6% CAGR

Rise in R&D activities and surge in application of stem cells for treatment of fatal chronic diseases drive the growth of the stem cell banking market.

PORTLAND, OR, UNITED STATES, October 9, 2024 /EINPresswire.com/ -- Allied Market Research recently published a report, titled, "Stem Cell Banking Market¹ by Service Type (Collection & Transportation, Processing, Analysis, and Storage), Utilization (Used and Unused), Cell Type (Umbilical Cord Stem Cell, Cord Blood, Cord Tissue, Placenta, Adult Stem Cell, and Embryonic Stem Cell), and Bank Type (Public and Private): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report, the global stem cell banking industry generated $4.29 billion in 2020, and is estimated to reach $16.55 billion by 2030, witnessing a CAGR of 15.6% from 2021 to 2030.

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 𝐁𝐚𝐧𝐤𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭?

Rise in R&D activities and surge in application of stem cells for treatment of fatal chronic diseases drive the growth of the global stem cell banking market. On the other hand, high cost associated with stem cell transplantation restrains the market growth. Contrarily, increased birthrate across the world presents opportunities in the coming years.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/4614

𝐓𝐨𝐩 𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 𝐁𝐚𝐧𝐤𝐢𝐧𝐠 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

• American CryoStem Corporation
• Americord Registry LLC
• Cordlife Group Limited
• Cordlife Group Limited
• Cryoholdco De LatinoAmerica
• S.A.P.I. DE C.V.
• StemCyte Cord Blood Bank
• Covis Pharma
• Global Cord Blood Corporation
• Smart Cells
• CSG BIO

The report provides a detailed analysis of these key players of the global 𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 𝐁𝐚𝐧𝐤𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭. These players have adopted different strategies such as agreement, partnership, acquisition, and business expansion to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 𝐁𝐚𝐧𝐤𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐛𝐞 𝐝𝐨𝐧𝐞 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐟𝐚𝐜𝐭𝐨𝐫𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:

Based on cell type, the umbilical cord stem cell segment accounted for the highest share in 2020, contributing to nearly two-thirds of the global stem cell banking market, and is expected to maintain its leadership status by 2030. This is attributed to surge in number of stem cell banks and advancements in umbilical cord stem cells. However, the adult stem cell segment is projected to witness the largest CAGR of 16.7% from 2021 to 2030, owing to rise in clinical trials for adult stem cells.

Based on bank type, the private segment accounted for the highest market share in 2020, contributing to nearly 90% of the global stem cell banking market, and is expected to maintain its dominance in terms of revenue throughout the forecast period. Moreover, this segment is projected to manifest the fastest CAGR of 15.7% from 2021 to 2030. This is attributed to increase in number of stem cell banks. The research also analyzes the public segment.

Based on region, North America contributed to the highest market share in terms of revenue in 2020, accounting for more than two-fifths of the global stem cell banking market, and is projected to continue its lead position by 2030. This is attributed to presence of key players for stem cell banking services and rise in number of hospitals in the region. However, Asia-Pacific is estimated to register the fastest CAGR of 16.5% during the forecast period. This is due to rise in demand for advanced therapy for disease and increase in the healthcare expenditure of patients.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/4614

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X

¹ https://www.alliedmarketresearch.com/stem-cell-banking-market